Dose optimisation of the synthetic reproductive hormone WOVA-FH for induced breeding ofClarias batrachus(Linnaeus, 1758)

2015 ◽  
Vol 25 (4) ◽  
pp. 365-372
Author(s):  
Bimal Kinkar Chand ◽  
Sourabh Kumar Dubey ◽  
Raman Kumar Trivedi ◽  
Mirza Masum Beg ◽  
Utpal Kumar Das ◽  
...  
2020 ◽  
Vol 105 (12) ◽  
pp. e4758-e4766
Author(s):  
Andrea Delbarba ◽  
Paolo Facondo ◽  
Simona Fisogni ◽  
Claudia Izzi ◽  
Filippo Maffezzoni ◽  
...  

Abstract Context Apo A-I Leu75Pro is a rare hereditary form of amyloidosis that mainly involves the kidney, the liver, and the testis. Objective To define the characteristics of organ damage and testis impairment in the largest cohort collected to date of men with Apo A-I Leu75Pro amyloidosis. Design, Setting, and Patients Retrospective study from a prospectively collected database of 129 male subjects >18 years with Apo A-I Leu75Pro amyloidosis from a reference center at the University Hospital of Brescia, Italy. Main outcome measures We evaluated liver and renal function, scrotal ultrasound, reproductive hormone levels, testis biopsy, hypogonadal symptoms, and fertility. Results Progressive involvement of testis, kidney, and liver was observed in 96/129 (74.4%) cases. Testis impairment was found in 88/129 patients (68.2%), liver in 59 (45.7%) and renal in 50 (38.8%). Testis damage was often the first manifestation of the disease and the only dysfunction in 30% of younger patients (<38 years). Testicular involvement was characterized mainly by primary (73/88 patients, 83.0%) and subclinical (8/88, 9.1%) hypogonadism. Almost all (85/88, 96.6%) also had high follicle-stimulating hormone, suggesting a primary global damage of endocrine and spermatogenic functions, and 30% of them did not conceive. Macroorchidism was found in 53/88 (60.2%) patients, especially in men <54 years (30/33, 90.9%). Apo A-I amyloid deposits were found in Sertoli cells, germinal epithelium, and vessel walls. Conclusion In men with Apo A-I Leu75Pro amyloidosis, testicular involvement is the hallmark of the disease, characterized by global primary testicular dysfunction and macroorchidism due to amyloid deposits.


2015 ◽  
Vol 84 (9) ◽  
pp. 1472-1481 ◽  
Author(s):  
Astrid Nagl ◽  
Nadja Kneidinger ◽  
Kairi Kiik ◽  
Heli Lindeberg ◽  
Tiit Maran ◽  
...  

2013 ◽  
Vol 16 (4) ◽  
pp. 544 ◽  
Author(s):  
SanjeevV Thomas ◽  
PS Sarma ◽  
C Nirmala ◽  
Annamma Mathai ◽  
SaraE Thomas ◽  
...  

Author(s):  
Sarah Johnson ◽  
Sarah Weddell ◽  
Sonya Godbert ◽  
Guenter Freundl ◽  
Judith Roos ◽  
...  

AbstractUrinary hormone level analysis provides valuable fertility status information; however, previous studies have not referenced levels to the ovulation day, or have used outdated methods. This study aimed to produce reproductive hormone ranges referenced to ovulation day determined by ultrasound.Women aged 18–40 years (no reported infertility) collected daily urine samples for one complete menstrual cycle. Urinary luteinising hormone (LH), estrone-3-glucuronide (E3G, an estradiol metabolite), follicle stimulating hormone (FSH) and pregnanediol-3-glucuronide (P3G, a progesterone metabolite) were measured using previously validated assays. Volunteers underwent trans-vaginal ultrasound every 2 days until the dominant ovarian follicle size reached 16 mm, when daily scans were performed until ovulation was observed. Data were analysed to create hormone ranges referenced to the day of objective ovulation as determined by ultrasound.In 40 volunteers, mean age 28.9 years, urinary LH surge always preceded ovulation with a mean of 0.81 days; thus LH is an excellent assay-independent predictor of ovulation. The timing of peak LH was assay-dependent and could be post-ovulatory; therefore should no longer be used to predict/determine ovulation. Urinary P3G rose from baseline after ovulation in all volunteers, peaking a median of 7.5 days following ovulation. Median urinary peak E3G and FSH levels occurred 0.5 days prior to ovulation. A persistent rise in urinary E3G was observed from approximately 3 days pre- until 5 days post-ovulation.This study provides reproductive hormone ranges referenced to the actual day of ovulation as determined by ultrasound, to facilitate examination of menstrual cycle endocrinology.


2001 ◽  
Vol 1220 ◽  
pp. 259-271
Author(s):  
Stephen H.D Jackson

2011 ◽  
Vol 150 (4) ◽  
pp. 427-433 ◽  
Author(s):  
T. J. Wood ◽  
A. W. Davis ◽  
C. S. Moore ◽  
A. W. Beavis ◽  
J. R. Saunderson

Sign in / Sign up

Export Citation Format

Share Document